| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 02/20/1996 | US5492897 Method for treating T-cell lymphoblastic leukemia with ara-G nucleoside derivatives |
| 02/20/1996 | CA2107110C Novel immunosuppressant agent from streptomyces braegensis |
| 02/15/1996 | WO1996004403A1 Systematic evolution of ligands by exponential enrichment: chimeric selex |
| 02/15/1996 | WO1996004295A1 5'-dithio-modified oligonucleotides |
| 02/15/1996 | WO1996004293A1 Antitumor indolopyrrolocarbazoles |
| 02/15/1996 | CA2195864A1 5'-dithio-modified oligonucleotides |
| 02/14/1996 | CN1030987C Process for indolo pyrrolo carbazole derivatives |
| 02/13/1996 | US5491229 Rapamycin derivative |
| 02/13/1996 | US5491133 Contacting eukaryotic cell in vitro with oligodeoxynucleotide which has complementarity for and is hybridizable to specifed messenger rna region and has modified phosphodiester linkage resistant to exonuclease degradation |
| 02/13/1996 | CA1338050C Macrolide compounds, their preparation and their use |
| 02/08/1996 | WO1996003134A1 Treatment of diarrhea with 2-substituted adenosine derivatives |
| 02/07/1996 | EP0695306A1 Enhanced triple-helix and double-helix formation with oligomers containing modified purines |
| 02/07/1996 | EP0695185A1 New method of treatment |
| 02/07/1996 | CN1116204A Processes for the diastereoselective synthesis of nucleosides |
| 02/06/1996 | US5489678 Photolabile nucleoside and peptide protecting groups |
| 02/06/1996 | US5489677 Nuclease resistant oligonucleotide analogs |
| 02/06/1996 | CA2057456C Anti depression pharmaceutical |
| 02/02/1996 | EP0702675A4 Method for palladium catalyzed carbon-carbon coupling and products |
| 02/01/1996 | WO1996002553A2 AMINO PURINE-β-D-RIBOFURANURONAMIDE DERIVATIVES |
| 02/01/1996 | WO1996002252A1 USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA |
| 02/01/1996 | CA2195345A1 Use of (s)-adenosyl-l-methionine (same) and its physiologically compatible salts for treating reperfusion damage triggered by temporary focal ischaemia |
| 01/31/1996 | EP0514513B1 Method and means for oligonucleotide synthesis |
| 01/31/1996 | EP0456817B1 Process for the preparation of 2-amino-9-(2,3,5-tri-0-benzyl-beta-d-arabinofuranosyl)adenine and novel intermediates |
| 01/31/1996 | CN1115600A Compositions containing 13-alkyl-23-imino derivative of LL-28249 compounds and their use |
| 01/30/1996 | US5488171 Intermediates for nucleotide analogs with viricide properties |
| 01/25/1996 | WO1996001834A1 2'-deoxy-2'-(substituted or unsubstituted methylidene)-4'-thionucleoside |
| 01/25/1996 | WO1996001833A1 Therapeutic compounds |
| 01/24/1996 | EP0693498A1 Antiviral compounds |
| 01/24/1996 | EP0693077A1 Antiviral compounds |
| 01/24/1996 | EP0663830A4 Method of treating lung disease with uridine triphosphates. |
| 01/24/1996 | CN1115320A Nucleosides and oligonucleotides having 2'-ether groups |
| 01/23/1996 | US5486604 Cyclic ADP ribose antagonists |
| 01/18/1996 | WO1996001115A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 01/18/1996 | DE4425280A1 Verwendung von (S)-Adenosyl-L-methionin (SAMe) und dessen physiologisch verträglichen Salzen zur Behandlung von Reperfusionsschäden, die durch temporäre fokale Ischämie ausgelöst werden Use of (S) -Adenosyl-L-methionine (SAMe) and its physiologically acceptable salts for treating reperfusion damage triggered by temporary focal ischemia |
| 01/17/1996 | EP0691979A1 Novel 5'-substituted nucleosides and oligomers produced therefrom |
| 01/17/1996 | EP0691978A1 Electronically conductive polymer/nucleotide copolymer, preparation method therefor and use thereof |
| 01/17/1996 | EP0691948A1 Protecting group for use in oligodeoxyribonucleotide synthesis |
| 01/17/1996 | EP0674646A4 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use. |
| 01/16/1996 | US5484911 Nucleoside 5'-diphosphate conjugates of ether lipids |
| 01/16/1996 | US5484908 Uracil or cytosine derivatives, detection of dna sequences |
| 01/16/1996 | US5484809 Prodrugs for oral administration containing taxol or substituted taxol covalently bound to a phospholipid |
| 01/16/1996 | US5484774 2, N6 -disubstituted adenosines, tri-O-ester derivatives and their pharmaceutical compositions to treat ischemias |
| 01/11/1996 | WO1996000797A1 Methods of screening for nucleoside analogs that are incorporated by hiv reverse transcriptase and cause incorrect base pairing |
| 01/11/1996 | WO1996000733A1 Diphosphate or triphosphate non-hydrolysable stable analogues and methods for their preparation |
| 01/11/1996 | WO1996000575A1 Polynucleoside chain having multiple nucleosides, the nucleosides coupled by guanidyl linkages |
| 01/11/1996 | DE4418690A1 Nucleoside 5'-mono-phosphate ester(s) of glyceryl di:ether derivs. |
| 01/10/1996 | EP0691333A2 Pyrimidine derivatives, process for their preparation and their use as precursors |
| 01/10/1996 | EP0690928A1 Nucleotide esters for use in nucleic acid sequencing |
| 01/10/1996 | EP0642527B1 Amphiphilic nucleoside phosphate analogs |
| 01/10/1996 | CN1030659C Derivatives of 10, 11, 12, 13-tetrahydrodesmycosin, processes for preparation, and use thereof in pharmaceuticals |
| 01/04/1996 | WO1996000229A1 Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
| 01/03/1996 | EP0690129A1 Novel entities for cancer therapy |
| 01/03/1996 | EP0690068A1 Novel 2'-methylidenenucleotide compound, process for producing the same, and pharmaceutical use thereof |
| 01/03/1996 | EP0689838A1 Use of diadenosine 5', 5'''- p1, p4 - tetraphosphate for curing ischemic anyocardial disease |
| 01/03/1996 | EP0689610A1 Dna sequencing by mass spectrometry via exonuclease degradation |
| 01/02/1996 | US5480992 Anomeric fluororibosyl amines |
| 01/02/1996 | US5480983 Adenosine derivatives, preparation methods and pharmaceutical compositions containing them |
| 01/02/1996 | US5480982 Storage stability |
| 01/02/1996 | US5480980 7-Deaza-2'-deoxyguanosine nucleotides and nucleic acids analogs thereof |
| 12/28/1995 | WO1995035305A1 Guanylic acid derivatives and their use as drugs |
| 12/28/1995 | WO1995035304A1 Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines |
| 12/28/1995 | WO1995035102A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 12/28/1995 | CA2193645A1 Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines |
| 12/28/1995 | CA2192950A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 12/27/1995 | EP0688784A2 3'-Modified oligonucleotide derivatives |
| 12/27/1995 | EP0688783A1 Method for preparing 2',deoxy-2',2'-difluornucleosides |
| 12/27/1995 | EP0688782A1 Stereoselective process for preparing protected 2',2'-difluorolactonen |
| 12/27/1995 | EP0688775A1 Method for the purification of 23 -E isomers of 23-imino derivatives of LL-F28249 compounds |
| 12/26/1995 | US5478951 Method for the purification of 23-E isomers of 23-imino derivatives of LL-F28249 compounds |
| 12/26/1995 | US5478929 Bioconversion products of 27-hydroxy avermectin |
| 12/26/1995 | US5478928 2',3'-dideoxy-4'-thioribonucleosides and synthetic precursors thereof |
| 12/26/1995 | US5478813 Antitumor substance BE-13793C derivatives |
| 12/26/1995 | US5478735 Process for producing acidic polycyclic ether antibiotic having anticoccidial and growth promant activity with Actinomadura |
| 12/26/1995 | CA2012093C Process for producing 2,2'-cyclocytidine and analogues thereof |
| 12/23/1995 | CA2152249A1 Method for the purification of 23-e isomers of 23-imino derivatives of ll-f28249 compounds |
| 12/20/1995 | EP0687959A1 Use of cyclic oligosaccharides or polysaccharides as charge control agents |
| 12/20/1995 | EP0533833B1 Phosphorous produgs |
| 12/20/1995 | EP0290496B2 Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery |
| 12/19/1995 | US5476932 Selective hydrolysis or deacylating of sugar part of acylcytidine compound |
| 12/19/1995 | US5476931 Reacting with a base in a mixed solvent containing alcohol |
| 12/19/1995 | US5476928 Modified nucleotides and polynucleotides and complexes form therefrom |
| 12/19/1995 | US5476766 Ligands of thrombin |
| 12/19/1995 | US5476659 Killing; particularly lymphocytic leukemia |
| 12/13/1995 | EP0686641A1 2'-deoxy-5-fluorouridine derivative, pharmaceutically acceptable salt thereof, process for producing the same, and antitumor drug |
| 12/13/1995 | EP0686161A1 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT |
| 12/13/1995 | EP0686160A1 Solution and solid-phase formation of glycosidic linkages |
| 12/13/1995 | EP0686150A1 Process for the preparation of C-nucleosides and C-nucleoside analogues, new C-nucleosides and C-nucleoside analogues and their use |
| 12/13/1995 | EP0544010B1 Process for producing 2',3'-dideoxy-beta-nucleoside |
| 12/13/1995 | EP0311694B1 Nucleoside derivatives and process for their preparation |
| 12/12/1995 | US5475096 Binding to three-dimensional targets |
| 12/07/1995 | WO1995032985A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer |
| 12/07/1995 | WO1995032984A1 New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 12/07/1995 | WO1995032983A1 Post exposure prevention of hiv |
| 12/07/1995 | WO1995032980A1 Synthesis of oligonucleotides |
| 12/07/1995 | WO1995032976A1 Polycyclic lactam derivatives for sensitizing multidrug-resistant cells to antitumour agents |
| 12/07/1995 | WO1995032975A1 Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents |
| 12/07/1995 | WO1995032974A1 Carbazole derivatives as agents against multi-drug resistance |
| 12/07/1995 | WO1995032718A1 2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease |
| 12/07/1995 | DE4418842A1 Colourless, thermostable, non-toxic cyclised oligo- or poly:saccharide use as charge controller or enhancer |
| 12/07/1995 | CA2190982A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer |